influenzajournal

[gsgs]

www.influenzajournal.com

http://onlinelibrary.wiley.com/doi/10.1111/j.1750-2659.2011.00209.x/pdf




© 2011 Blackwell Publishing Ltd
Edited By: Alan W. Hampson

Content from Influenza and Other Respiratory Viruses is no longer all free for everyone. Don't miss out on the only journal to specialise exclusively on influenza and other respiratory viruses, recommend that your librarian subscribe.


current issue:
http://onlinelibrary.wiley.com/doi/10.1111/irv.2011.5.issue-4/issuetoc
Rash, an uncommon but existing feature of H1N1 influenza among children (pages 223–224)
Isolation of Aspergillus in three 2009 H1N1 influenza patients (pages 225–229)
Clinical features, complications and mortality in critically ill patients with 2009 influenza A(H1N1) in Sfax,Tunisia (pages 230–240)
Clinical epidemiology comparison of H1N1 RT-PCR-positive and RT-PCR-negative pneumonia during the 2009–2010 pandemic in Mansoura University Hospitals, Egypt (pages 241–246)
Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada (pages 247–255)
Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, Thailand (pages 256–267)
Detection of influenza viral gene in European starlings and experimental infection (pages 268–275)
Analysis of influenza A viruses of subtype H1 from wild birds, turkeys and pigs in Germany reveals interspecies transmission events (pages 276–284)
Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010 (pages 288–295)






http://twitter.com/#!/InfluResViruses

http://www.isirv.org/



wiley online library, free registration , 3 pages terms and conditions
http://onlinelibrary.wiley.com/user-registration





Conclusions  Influenza transmission was not reduced by interventions to promote hand washing and face mask use.


http://onlinelibrary.wiley.com/doi/10.1111/j.1750-2659.2011.00209.x/pdf

 (2011) A decision support tool for evaluating the impact of a diagnostic-capacity and antiviral-delivery constrained intervention strategy on an influenza pandemic.
 (2011) A monoclonal antibody-based ELISA for differential diagnosis of 2009 pandemic H1N1.
 (2011) A serial cross-sectional serologic survey of 2009 Pandemic (H1N1) in Hong Kong: implications for future pandemic influenza surveillance.
 (2011) A strategy to provide influenza antiviral resistance testing for patients with a clinical suspicion of resistance, United States 2009–2010.
 (2011) A university–corporate partnership to enhance vaccination rates among the elderly: an example of a corporate public health care delivery.
 (2011) A(H1N1)2009 pandemic in France: epidemiological features based on virological surveillance.
 (2011) Activation of the highly pathogenic avian influenza virus replication by membrane-bound proteases MSPL and TMPRSS13 and its inhibition by the protease inhibitors.
 (2011) Adamantane and oseltamivir dual resistance in seasonal influenza A (H1N1) viruses.
 (2011) Antiviral activity of a selective COX- 2 inhibitor NS-398 on avian influenza H5N1 infection.
 (2011) Antiviral drug resistance study of influenza viruses isolated in Mongolia in recent years.
 (2011) Association between pandemic and seasonal influenza vaccination and haemagglutination antibody titers against A/H1N1v: a national representative survey in France, nested in the ‘‘Cohorts for Pandemic Influ
 (2011) Attenuation of respiratory immune responses by antiviral neuraminidase inhibitor treatment and boost of mucosal immunoglobulin A response by co-administration of immuno-modulator clarithromycin in paediatric 
 (2011) Avian antibodies to combat potential H5N1 pandemic and seasonal influenza.
 (2011) Basic results of development of a production technology and control of a pandemic influenza A /H5N1 vaccine.
 (2011) Behavior of influenza A H1N1 2009 in infants under 5 years old in Tucuma´n, Argentina.
 (2011) Characterisation of stability, cytotoxicity, and skin sensitisation and irritation for respirators with antiviral coating.
 (2011) Co-amplified quantitative real-time PCR: an objective comparison of H1N1 viral load between patients with mild, moderate, and severe disease.
 (2011) Co-infecting viruses in pandemic H1N1 and seasonal influenza positive human respiratory samples.
 (2011) Community psychological and behavioral responses through the first wave of 2009 pandemic (H1N1) in Hong Kong.
 (2011) Competitive transmissibility and fitness of oseltamivir-sensitive and resistant pandemic influenza H1N1 viruses in ferrets.
 (2011) Concepts and applications for influenza antigenic cartography.
 (2011) Continuing evolution of H9N2 influenza viruses endemic in poultry in southern China.
 (2011) Cross-protection elicited by MF59-adjuvanted vaccine during seasons with good or partial matching between vaccine strain and clinical isolates.
 (2011) Cross-reactive antibody response to pandemic H1N1 2009 in mainland China.
 (2011) Design of an automated laboratory for high-throughput influenza surveillance.
 (2011) Detection and isolation of pandemic (H1N1) 2009 influenza virus from stool sample.
 (2011) Detection of anti-neuraminidase antibody in preclinical and clinical studies of live influenza vaccine.
 (2011) Development and implementation of the WHO public health research agenda for influenza.
 (2011) Development of pandemic live attenuated influenza vaccine (LAIV) in Russia.
 (2011) Development of production technology and pre-clinical testing of a pandemic influenza A/H1N1 vaccine.
 (2011) Development of rapid antigen test for pandemic (H1N1) 2009 virus.
 (2011) Development of the influenza B reassortant NYMC BX-35 for use as seed virus for influenza B vaccine production.
 (2011) Diagnosis of bacterial complications of seasonal and pandemic influenza in hospitalized adults; can serum procalcitonin (ProCT) help? .
 (2011) Differential cell culture susceptibility and proliferative response to avian, human, and swine influenza viruses.
 (2011) Differential onset of apoptosis in avian influenza H5N1 and seasonal H1N1 virus infected human bronchial and alveolar epithelial cells: an in vitro and ex vivo study.
 (2011) Epidemiologic study of human influenza infection in Korea from 1999 to 2007: origin and evolution of A /Fujian /411 /2002-like strains.
 (2011) Epidemiological diversity analysis upon the incidence of 2009 novel H1N1 flu among school children within and among small regional communities, Japan.
 (2011) Evaluation of a new protocol for universal detection of human influenza A and B viruses and simultaneous sub-typing of influenza A(H1N1) 2009 virus by multiplex real-time RT-PCRs.
 (2011) Evaluation of growth, genetic, and antigenic characteristics of pandemic H1N1 viruses isolated and passaged in qualified MDCK suspension cells (MDCK33016PF) and embryonated hen eggs.
 (2011) Evaluation of model prediction during the early phase of the 2009 influenza pandemic in Italy.
 (2011) Evolution of H6N1 avian influenza viruses in chickens.
 (2011) Evolutionary studies of 2009 H1N1 pandemic via next generation sequencing (NGS) : circulating influenza A from the worldwide locations are the variants of original 2009 H1N1.
 (2011) Exploring alternate immune hypotheses in dynamical models of the 1918–1919 influenza pandemic.
 (2011) Genetic and antiviral drug susceptibility profiles of pandemic A(H1N1)v influenza virus circulating in Portugal.
 (2011) Genetic characterization of H4, H5, and H13 type avian influenza viruses isolated from wild birds in Kazakhstan.
 (2011) GISAID – a global initiative on sharing all influenza data.
 (2011) H9N2 influenza virus acquires intravenous pathogenicity on the introduction of a pair of di-basic amino acid residues at the cleavage site of the hemagglutinin and consecutive passages in chickens.
 (2011) H9N2 influenza virus vaccine prepared from a non-pathogenic isolate from a natural reservoir conferred protective immunity against the challenge with a human H9N2 virus in mice.
 (2011) Identification of dual receptor-binding specific strains of human H5N1 viruses in China.
 (2011) Identification of human annexin A6 as a novel cellular interactant of influenza A M2 protein: implications for influenza life cycle.
 (2011) Impact of primary influenza infection on the immune response to secondary bacterial infection in aged mice.
 (2011) Inactivation of influenza viruses by coated respirators: in vitro infectivity assays.
 (2011) Influenza C virus NS1 protein up-regulates viral mRNA splicing.
 (2011) Influenza virus surveillance in migratory ducks and sentinel ducks at Poyang Lake, China.
 (2011) Influenza virus-cytokine-protease cycles are principal mechanisms of multi-organ failure in severe influenza and therapeutic approaches.
 (2011) Influenza viruses in wild birds in Hong Kong, 2003–2010.
 (2011) Influenza, MRSA, cytokines: diagnosis, treatment, prevention – a possible strategy for outpatient care.
 (2011) Interactions of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.
 (2011) IPMiner: a progenitor gene identifier for influenza A virus.
 (2011) Large-scale sequence analysis of influenza A hemagglutinin (HA) : insights into a unified system for lineage assignment.
 (2011) Logistical feasibility and potential benefits of a population-wide passive immunotherapy program during an influenza pandemic.
 (2011) Low doses of AF03-adjuvanted pandemic influenza A/H5N1 and A/H1N1 vaccines protect ferrets against infection after homologous and heterologous viral challenge.
 (2011) NS deletions convert the 2009-H1N1 pandemic virus into a live attenuated vaccine.
 (2011) Oseltamivir-resistant infection of pandemic (H1N1) 2009 influenza virus in South Korea.
 (2011) Outbreak of H1N1 influenza – 2009: behavior of influenza H1N1 in school children in the province of Tucuma´n, Argentina.
 (2011) Outbreak of viral respiratory infections in an aged care facility in NSW – lessons about a pandemic virus.
 (2011) Pandemic influenza 2009 in Russia: isolation, antigenic analysis, and biological properties of viruses.
 (2011) Pandemic influenza in Russia: detection and molecular characterization of the H1N1v virus.
 (2011) Pandemic influenza vaccination of hypogammaglobulinemic patients induces normal or elevated influenzaspecific CD4+ Th1-cell responses.
 (2011) Pathogenicity and transmissibility of the pandemic H1N1 2009-related influenza viruses in mice, ferrets, and pigs.
 (2011) Patterns of viral shedding in pandemic and seasonal influenza virus infections in a community setting.
 (2011) Peculiarities of reassortment of a cold-adapted influenza A master donor virus with influenza A viruses containing hemagglutinin and neuraminidase of avian H5N1 origin.
 (2011) Phylogenetic analyses of pandemic influenza viruses.
 (2011) Potent inhibition of pandemic influenza H1N1 (2009) virus propagation by novel chemically synthesized compounds.
 (2011) Potential of the real-time and label-free cell sensor impedance technology to transform cell based infectivity assays for influenza viruses.
 (2011) Prediction of the antigenic changes of the pandemic (H1N1) 2009 influenza virus hemagglutinin.
 (2011) Proof of principle for an immunological model to explain mortality variations over the three waves of the 1918–1919 pandemic.
 (2011) Prospective estimation of the effective reproduction number of pandemic influenza in Hong Kong.
 (2011) Protection against H5N1 influenza by immunoglobulin single variable domains.
 (2011) Protection of mice against influenza A and B virus infection by mucosal immunization with Bacillus firmus as an adjuvant.
 (2011) Protective role of protease-activated-receptor 2 against influenza viruses occurs through an ERK independent pathway: implication for new influenza therapy.
 (2011) Quantitative assessment of early intervention strategies: a case study of 2009 H1N1 pandemic in Taiwan.
 (2011) Rapid detection of pandemic influenza in the presence of seasonal influenza.
 (2011) Rapid detection of reassortment of pandemic H1N1/2009 influenza virus.
 (2011) Receptor specificity and replication in human airway cultures of H1N1pdm viruses with HA mutations D222G and Q223R.
 (2011) Relationship of subtype influenza A pandemic strains to virucidal activity of a quaternary ammonium disinfectant.
 (2011) Relationships between reactogenicity and age, dose number and immunogenicity in 937 children receiving two doses of ASO3B-adjuvanted split virion or whole virus H1N1 influenza A 2009 pandemic vaccines.
 (2011) Replication and innate host response of influenza A virus in lung microvascular endothelial cells: new insights into systemic infection and pathogenesis.
 (2011) Replication of avian and seasonal influenza viruses in human bronchus and lung.
 (2011) Results of influenza virus detection using different methods.
 (2011) Role of palmitoylation of membrane protein CM2 in influenza C virus replication.
 (2011) Roles of adjuvant IgV combined with influenza M2e based virus like particle in the immune response and cross protection.
 (2011) Route of H5N1 exposure in ferrets affects pathogenesis and severity of disease.
 (2011) Safety and efficacy of a novel live attenuated influenza vaccine against pandemic H1N1 in swine.
 (2011) Seroprevalence of antibody to influenza A(H1N1) 2009 in Australian blood donors – before and after the 2009 influenza season, and prior to the 2010 Southern Hemisphere winter.
 (2011) Standardization of the classic MUNANA-based neuraminidase activity assay for monitoring anti-viral resistance in influenza.
 (2011) Study of transmissibility of wild type and cold-adapted influenza viruses in guinea pigs.
 (2011) Surveillance and monitoring of pandemic flu in a resource limited environment: a case of Djibouti and a WHO-Copanflu International Study preliminary report.
 (2011) Surveillance and monitoring of pandemic flu in a resource limited environment: a case of Djibouti and a WHO-Copanflu International Study preliminary report.
 (2011) Surveillance of influenza viruses in swine in Hong Kong abattoir: methods and feasibility.
 (2011) Susceptibility of human influenza viruses to neuraminidase inhibitors (season 2008–2009).
 (2011) Swine influenza in Vietnam: preliminary results of epidemiological studies.
 (2011) Systematic random versus ad hoc non random sampling strategy: does it modify estimations of influenza vaccine efficiency?  5 (Suppl.
 (2011) The effectiveness of seasonal influenza vaccine in preventing pandemic and seasonal influenza infection: a randomized controlled trial.
 (2011) The first wave of influenza A(H1N1)2009 pandemics in Mongolia.
 (2011) The impacts of school resumption on the incidence of pandemic (H1N1) 2009 in school students.
 (2011) The NA-XTDTM Influenza Neuraminidase Assay Kit: extended-glow chemiluminescence assay system for highly sensitive influenza neuraminidase assays.
 (2011) The NF-kappaB-inhibitor SC75741 efficiently blocks H5N1 influenza virus propagation in vitro and in vivo without the tendency to induce resistant virus variants.
 (2011) The polyphenol rich plant extract CYSTUS052 is highly effective against H5N1 and pandemic H1N1v influenza A virus.
 (2011) The regional distribution of different types of influenza receptors in cultured human alveolar epithelial cells and correlation with in vitro infection.
 (2011) The role of innate sensing receptors in H5N1 associated hyper-induction of cytokines.
 (2011) Transmissibility of pandemic H1N1 and genetically related swine influenza viruses in ferrets.
 (2011) Transmission of pandemic H1N1 2009 influenza in households and school settings: comparison with seasonal influenza.
 (2011) Tropism and innate host response of the 2009 pandemic H1N1 influenza virus compared with related swine influenza viruses and reassortants in ex vivo and in vitro cultures of the human respiratory tract and co
 (2011) Unique characteristics of long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) that explains its long-lasting activity.
 (2011) Usefulness of a self-blown nasal discharge specimen for use with immunochromatography based influenza rapid antigen test.
 (2011) Virological and autopsy findings in suspected and confirmed fatal cases of 2009 H1N1 pandemic influenza in the Czech Republic – preliminary results.
 (2011) Virus-free ELISA method for the determination of influenza A/H1N1/2009 antibodies in human serum.
 (2011) Virus-specific CD4+ and CD8+ memory T-cells in young volunteers after immunization with pandemic live attenuated reassortant influenza vaccines A (H5N2) and A (H1N1) .
 (2011) WHO public health research agenda for influenza: road mapping for information gaps and research needs in a pandemic scenario.
 (2011) WHO public health research agenda for influenza: road mapping for information gaps and research needs in an inter-pandemic scenario.
 (2011) WHO public health research agenda for influenza: tools for strategic communication during pandemic and inter-pandemic periods.